2018 annual financial data
Revolution Medicines 2018 Operating margin
Revolution Medicines 2018 operating margin with verified reported values.
Direct answer
Operating margin was -200%.
Operating income was -40,329,000 USD and net income was -41,789,000 USD.
Operating cash flow was 1,213,000 USD.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,165,000 USD
- Operating income
- -40,329,000 USD
- Net income
- -41,789,000 USD
- Operating cash flow
- 1,213,000 USD